Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
3074
First IPO Date
July 31, 2014
| Name | Title | Pay | Year Born |
| Monica Manotas | Chief Executive Officer, Interim Head of the Partnering Business division & Member of Management Board | 1.04M | 1973 |
| Tania Micki | Chief Financial Officer & Member of Management Board | 636,000 | 1971 |
| Sarah Vowles | Director Sustainability & Corporate Communications | 0 | N/A |
| Ulrich Kanter | Executive Vice President, Global Head of Operations & IT and Member of Management Board | 0 | 1963 |
| Andreas Wilhelm | EVice President of Legal, Qua. & Regu. Affairs, Gen. Cou., Sec. of the Board of Dir. & Mem. of Mgmt Board | 0 | 1969 |
| Carsten Boegh | Chief Technology Officer, Executive Vice President, Head Research & Development & Member of the Management Board | 0 | 1968 |
| Erik Norström | Head of Corporate Development, Executive Vice President & Member of Management Board | 0 | 1973 |
| Martin Brandle | Senior Vice President of Corporate Communications & Investor Relations | 0 | N/A |
| Wolfgang Deuringer | President of Sales International | 0 | N/A |
| Camila Japur | Chief Financial Officer | 0 | 1982 |
| Ingrid Purgstaller | Chief People Officer & Member of the Management Board | 0 | 1980 |
| Mukta Acharya | EVP, Head of the Life Sciences Business Division & Member of the Management Board | 0 | 1984 |
Tecan Group AG, established in 1980 and based in Männedorf, Switzerland, provides advanced laboratory instruments and comprehensive solutions. The company caters to a wide range of clients globally, including pharmaceutical and biotechnology companies, academic research institutions, and forensic and diagnostic laboratories. Its operations are divided into two primary segments: Life Sciences Business and Partnering Business. The company's product portfolio is extensive, featuring automated liquid handling and robotic systems, microplate readers and washers, essential consumables, next-generation sequencing (NGS) reagents, immunoassays, and specialized software. Noteworthy proprietary solutions include Tecan Laberwax, an automation platform, and Resolvex, designed for intelligent sample preparation in diverse fields such as genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, and ELISA applications. Furthermore, Tecan develops and manufactures critical components like precision pumps, valves, and robotic arms, alongside developer software, for other laboratory instrument manufacturers serving life science research, diagnostics, and various industrial sectors. Key instrument lines include Synergence, Freedom EVO, and Fluent. Tecan Group AG has a significant international presence, conducting business throughout Switzerland, other European countries, North America, and Asia.